| # | Company | Ticker | Exchange | Industry | Country | Market Cap | 1W | 1Y change |
|---|---|---|---|---|---|---|---|---|
| 1 |  Novartis AGNOVNSIX | NOVN | SIX | Gene & Cell Therapy Companies | Switzerland | $286.3B | +4.7% | +14.6% |
| 2 |  AstraZeneca PLCAZNNYSE | AZN | NYSE | Pharmaceutical Drug Companies | United Kingdom | $256.5B | — | -3.2% |
| 3 | TMO | NYSE | Instruments & Meters Companies | United States | $255.1B | +4.9% | +28.0% | |
| 4 |  Kite Pharma (Gilead Sciences)GILDNASDAQ | GILD | NASDAQ | Gene & Cell Therapy Companies | United States | $193.7B | +3.3% | +27.2% |
| 5 |  Abbott LaboratoriesABTNYSE | ABT | NYSE | Health Food Factories | United States | $182.7B | +5.3% | -18.4% |
| 6 |  Danaher CorporationDHRNYSE | DHR | NYSE | Instruments & Meters Companies | United States | $161.0B | +4.2% | +9.6% |
| 7 |  Vertex Pharmaceuticals Inc.VRTXNASDAQ | VRTX | NASDAQ | Gene & Cell Therapy Companies | United States | $126.6B | -2.0% | +19.9% |
| 8 | BMY | NYSE | Gene & Cell Therapy Companies | United States | $122.0B | +1.1% | +37.0% | |
| 9 |  WuXi AppTec Co., Ltd.02359HKEX | 02359 | HKEX | Gene & Cell Therapy Manufacturers & Suppliers | China | $75.9B | -5.7% | +93.5% |
| 10 |  Lonza Group AGLONNSIX | LONN | SIX | Gene & Cell Therapy Manufacturers & Suppliers | Switzerland | $51.2B | +5.6% | +5.0% |
| 11 |  GE HealthCareGEHCNASDAQ | GEHC | NASDAQ | Medical Diagnostic Equipment Companies | United States | $31.6B | +5.8% | -6.0% |
| 12 |  Mindray300760SZSE | 300760 | SZSE | Instruments & Meters Manufacturers | China | $30.4B | +3.7% | -20.8% |
| 13 |  Philips HealthcarePHGNYSE | PHG | NYSE | Home Medical Devices Brands | Netherlands | $25.1B | +6.2% | -9.8% |
| 14 |  GenScript Biotech Corporation1548HKEX | 1548 | HKEX | Gene & Cell Therapy Manufacturers & Suppliers | China | $9.7B | -21.5% | +109.0% |
| 15 |  Sysmex6869TSE | 6869 | TSE | Medical Diagnostic Equipment Companies | Japan | $7.1B | — | -2.1% |
| 16 |  Legend Biotech CorporationLEGNNASDAQ | LEGN | NASDAQ | Gene & Cell Therapy Companies | United States | $3.6B | -0.8% | -42.2% |
| 17 |  Sarepta Therapeutics Inc.SRPTNASDAQ | SRPT | NASDAQ | Gene & Cell Therapy Companies | United States | $1.8B | -4.2% | -24.0% |
| 18 |  Roche DiagnosticsROGSIX | ROG | SIX | Medical Diagnostic Equipment Manufacturers | Switzerland | Market data pending | -9.5% | — |
- 01
Novartis AG
NOVNSIXSwitzerland
$286.3B
+4.7% 1W·+14.6% 1Y
- 02
AstraZeneca PLC
AZNNYSEUnited Kingdom
$256.5B
— 1W·-3.2% 1Y
- 03
Thermo Fisher Scientific Inc.
TMONYSEUnited States
$255.1B
+4.9% 1W·+28.0% 1Y
- 04
Kite Pharma (Gilead Sciences)
GILDNASDAQUnited States
$193.7B
+3.3% 1W·+27.2% 1Y
- 05
Abbott Laboratories
ABTNYSEUnited States
$182.7B
+5.3% 1W·-18.4% 1Y
- 06
Danaher Corporation
DHRNYSEUnited States
$161.0B
+4.2% 1W·+9.6% 1Y
- 07
Vertex Pharmaceuticals Inc.
VRTXNASDAQUnited States
$126.6B
-2.0% 1W·+19.9% 1Y
- 08
Bristol-Myers Squibb Company (BMS)
BMYNYSEUnited States
$122.0B
+1.1% 1W·+37.0% 1Y
- 09
WuXi AppTec Co., Ltd.
02359HKEXChina
$75.9B
-5.7% 1W·+93.5% 1Y
- 10
Lonza Group AG
LONNSIXSwitzerland
$51.2B
+5.6% 1W·+5.0% 1Y
- 11
GE HealthCare
GEHCNASDAQUnited States
$31.6B
+5.8% 1W·-6.0% 1Y
- 12
Mindray
300760SZSEChina
$30.4B
+3.7% 1W·-20.8% 1Y
- 13
Philips Healthcare
PHGNYSENetherlands
$25.1B
+6.2% 1W·-9.8% 1Y
- 14
GenScript Biotech Corporation
1548HKEXChina
$9.7B
-21.5% 1W·+109.0% 1Y
- 15
Sysmex
6869TSEJapan
$7.1B
— 1W·-2.1% 1Y
- 16
Legend Biotech Corporation
LEGNNASDAQUnited States
$3.6B
-0.8% 1W·-42.2% 1Y
- 17
Sarepta Therapeutics Inc.
SRPTNASDAQUnited States
$1.8B
-4.2% 1W·-24.0% 1Y
- 18
Roche Diagnostics
ROGSIXSwitzerland
—
-9.5% 1W·— 1Y
Showing 1–18 of 18